RegionsNorth AmericaEuropeIsraelIndiaSoutheast AsiaEast AsiaLatin AmericaMiddle EastAfricaOceaniaGlobalUpdated 14 October 2026
AcquiredStartups
SearchExit tracker
Top startup acquisitions · Healthtech & bio

Top Healthtech & bio startup acquisitions in February 2026

We tracked 3 startup exits in February 2026. 2 disclosed a price, worth $1.17bn in total. The biggest was Hims & Hers buying Eucalyptus for $1.15bn, ahead of Techmatrix and Medmain at $15m.

All Healthtech & bio startup acquisitions →
  1. #DateAcquirer → StartupSectorLocationPriceSize
  2. 119 FebHims & Hers → EucalyptusHims & Hers agrees to buy Australian telehealth company Eucalyptus for up to $1.15 billionHealthtech & bioSydney, Australia$1.15bn$1bn+
  3. 217 FebTechmatrix → MedmainTechmatrix agrees to take control of pathology AI startup Medmain for about ¥2.3 billionHealthtech & bioFukuoka, Japan$15m< $50m
  4. 310 FebHarbor Health → RipplHarbor Health acquires dementia care startup Rippl and expands into FloridaHealthtech & bioSeattle, United StatesUndisclosedUndisclosed